Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryIndustrial Conglomerates
SectorN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees71,000
Next Earnings Date4/16/2020 (Estimated)
OptionableOptionable
Danaher (NYSE:DHR) Frequently Asked Questions
What is Danaher's stock symbol?
Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
How often does Danaher pay dividends? What is the dividend yield for Danaher?
Danaher announced a quarterly dividend on Tuesday, December 10th. Stockholders of record on Friday, December 27th will be paid a dividend of $0.17 per share on Friday, January 31st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.41%. The ex-dividend date is Thursday, December 26th. View Danaher's Dividend History.
How were Danaher's earnings last quarter?
Danaher Co. (NYSE:DHR) posted its earnings results on Thursday, January, 30th. The conglomerate reported $1.28 earnings per share for the quarter, beating analysts' consensus estimates of $1.25 by $0.03. The conglomerate had revenue of $4.87 billion for the quarter, compared to analyst estimates of $4.80 billion. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.28 EPS. View Danaher's Earnings History.
When is Danaher's next earnings date?
What guidance has Danaher issued on next quarter's earnings?
Danaher updated its FY20 earnings guidance on Thursday, January, 30th. The company provided EPS guidance of $4.80 to $4.90 for the period, compared to the Thomson Reuters consensus estimate of $5.38.
What price target have analysts set for DHR?
17 brokerages have issued 1-year target prices for Danaher's stock. Their forecasts range from $130.00 to $195.00. On average, they anticipate Danaher's share price to reach $166.28 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Danaher.
What is the consensus analysts' recommendation for Danaher?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.
Has Danaher been receiving favorable news coverage?
Media headlines about DHR stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Danaher earned a news impact score of 2.0 on InfoTrie's scale. They also gave news stories about the conglomerate a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Danaher.
Are investors shorting Danaher?
Danaher saw a drop in short interest in January. As of January 31st, there was short interest totalling 9,650,000 shares, a drop of 13.9% from the January 15th total of 11,210,000 shares. Based on an average daily trading volume, of 11,060,000 shares, the short-interest ratio is currently 0.9 days. Currently, 1.5% of the company's shares are sold short. View Danaher's Current Options Chain.
What other stocks do shareholders of Danaher own?
Who are Danaher's key executives?
Danaher's management team includes the folowing people:
- Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 58)
- Mr. Daniel L. Comas, Exec. VP (Age 55)
- Mr. William K. Daniel II, Exec. VP (Age 54)
- Mr. Rainer M. Blair, Exec. VP (Age 55)
- Mr. Joakim Weidemanis, Exec. VP (Age 49)
Who are Danaher's major shareholders?
Danaher's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (0.77%), Goldman Sachs Group Inc. (0.74%), UBS Asset Management Americas Inc. (0.69%), Parnassus Investments CA (0.67%), Findlay Park Partners LLP (0.49%) and Fred Alger Management LLC (0.47%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.
Which institutional investors are selling Danaher stock?
DHR stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Marshall Wace North America L.P., AQR Capital Management LLC, UBS Asset Management Americas Inc., Marshall Wace LLP, Commerzbank Aktiengesellschaft FI, Prudential Financial Inc. and Findlay Park Partners LLP. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.
Which institutional investors are buying Danaher stock?
DHR stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Madison Asset Management LLC, Loomis Sayles & Co. L P, Fred Alger Management LLC, Beacon Investment Advisory Services Inc., Arthur M. Cohen & Associates LLC, Fiera Capital Corp and Candriam Luxembourg S.C.A.. View Insider Buying and Selling for Danaher.
How do I buy shares of Danaher?
Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Danaher's stock price today?
One share of DHR stock can currently be purchased for approximately $165.95.
MarketBeat Community Rating for Danaher (NYSE DHR)
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
